Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae.
John C Achenbach, Jessica Hill, Joseph P M Hui, Michael G Morash, Fabrice Berrue, Lee D Ellis
Zebrafish August 2018 DOI: 10.1089/zeb.2017.1541 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental animal study Peer reviewed |
|---|---|
| Population | Zebrafish larvae |
| Interventions | Δ9-tetrahydrocannabinol (THC) cannabidiol (CBD) |
| Topics | Cannabis CBD |
| Keywords | Behavior Cannabinoid Metabolism Zebrafish |
| Key findings | THC and CBD produced distinct behavioral patterns and concentration-response profiles in zebrafish larvae, and each compound's uptake kinetics appeared to correlate with behavioral changes. Combining THC and CBD shifted both behavioral activity and uptake kinetics compared with either compound alone. The authors report that THC/CBD-derived metabolites detected in larvae resemble those found in mammalian systems, and propose the model for testing additional cannabinoids and plant extracts. |
Abstract
The Cannabis sativa plant contains numerous phytocannabinoids and terpenes with known or potential biological activity. For decades, plant breeders have been breeding the Cannabis plant to control for a desired ratio of the major cannabinoids. A high-throughput in vivo model to understand the relationship between the chemical composition of different strains and their therapeutic potential then becomes of value. Measuring changes in the behavioral patterns of zebrafish larvae is an established model with which to test the biological activity of neuroactive compounds. However, there is currently little information regarding the uptake kinetics and metabolism of compounds by larvae. In this study, we chose to compare the uptake kinetics and metabolism of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) alone or in combination with their effects on larval behavior. We have shown that both compounds have distinct behavioral patterns and concentration response profiles. Additionally, the uptake kinetics observed for each compound appears to correlate with the change in behavior observed in the behavioral assays. When combinations of THC and CBD were tested there were shifts in both the behavioral activity and the uptake kinetics of each compound compared with when they were tested alone. Finally, the THC/CBD-derived metabolites detected in the larvae are similar to those found in mammalian systems. This study thus provides a model for further testing of additional cannabinoids and potentially plant extracts.
Comparable studies
Other preclinical and animal studies on CBD, most cited first.
Citations in the library
Cites 4
- Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway. European Neuropsychopharmacology February 2017
- Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology November 2011
- The endocannabinoid system: emotion, learning and addiction. Addiction Biology June 2008
- Cannabinoid-induced alterations in brain disposition of drugs of abuse. Biochemical Pharmacology June 1, 2001